Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Escitalopram effects on fear conditioning
NCT01398514Phase 4Completed
- Sponsor
- Massachusetts General Hospital
- Start
- Oct 2008
- Primary completion
- Jun 2011
- Modality
- Small Molecules
01
Overview
A Phase 4 trial of escitalopram in anxiety disorders, post-traumatic stress disorder (PTSD), sponsored by Massachusetts General Hospital. Started Oct 2008; status: completed.
02
Drugs
escitalopram
03
Conditions
anxiety disorderspost-traumatic stress disorder (PTSD)
Beyond the preview
Go deeper on NCT01398514.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01398514.